regenerative medicine

Mount Sinai launches regenerative medicine outpost to translate research into medicines
Mount Sinai launches regenerative medicine outpost to translate research into medicines
Fierce Biotech
Mount Sinai
regenerative medicine
R&D
Flag link:
Regenerative medicine clinical trials continue to rise
Regenerative medicine clinical trials continue to rise
Clinical Trials Arena
regenerative medicine
stem cells
clinical trials
Flag link:
Industry seeks clarity on FDA’s standards recognition process for regenerative medicines
Industry seeks clarity on FDA’s standards recognition process for regenerative medicines
RAPS.org
FDA
regulatory
regenerative medicine
Flag link:
Mogrify, Astellas Pharma partner for sensorineural hearing loss treatment
Mogrify, Astellas Pharma partner for sensorineural hearing loss treatment
Pharmaceutical Business Review
Mogrify
Astellas
regenerative medicine
hearing loss
Flag link:
Enzyvant to build regenerative medicine manufacturing plant in North Carolina
Enzyvant to build regenerative medicine manufacturing plant in North Carolina
Fierce Pharma
Enzyvant
North Carolina
regenerative medicine
drug manufacturing
Flag link:
Big Pharma partnerships, record $22.7B investment raise profile of regenerative medicine in 2021
Big Pharma partnerships, record $22.7B investment raise profile of regenerative medicine in 2021
Fierce Biotech
regenerative medicine
gene editing
gene therapy
Big Pharma
Intellia Therapeutics
Flag link:
7 Medical Device Sectors Ripe for M&A
7 Medical Device Sectors Ripe for M&A
Medical Devices and Diagnostics Industry
devices
Medtech
M&A
TMVR
pulsed field ablation
digital therapeutics
artificial intelligence
thrombectomy
intraocular lenses
stem cells
regenerative medicine
Flag link:
Backed by Bayer's Leaps, Boston-based Cellino lands $80M for cell therapy-in-box
Backed by Bayer's Leaps, Boston-based Cellino lands $80M for cell therapy-in-box
Endpoints
Cellino
funding
Bayer
cell therapy
regenerative medicine
Flag link:
Altos bursts out of stealth with $3B, a dream team C-suite and a wildly ambitious plan to reverse disease
Altos bursts out of stealth with $3B, a dream team C-suite and a wildly ambitious plan to reverse disease
Fierce Biotech
Altos Labs
funding
regenerative medicine
Flag link:
Hybrigenics says it wants a merger with Bone Therapeutics
Hybrigenics says it wants a merger with Bone Therapeutics
Pharmaforum
M&A
Bone Therapeutics
Hybrigenics
regenerative medicine
Flag link:
Already sitting on a major stem cell bank, Generate looks to grow its regenerative medicines business
Already sitting on a major stem cell bank, Generate looks to grow its regenerative medicines business
Endpoints
Generate Life Sciences
stem cells
regenerative medicine
Flag link:
Mallinckrodt obtains FDA approval for StrataGraft to treat thermal burns
Mallinckrodt obtains FDA approval for StrataGraft to treat thermal burns
Pharmaceutical Business Review
Mallinckrodt
FDA
StrataGraft
thermal burns
burns
regenerative medicine
Flag link:
Regenerative medicine biotech Surrozen aims for the Nasdaq in $212M SPAC deal
Regenerative medicine biotech Surrozen aims for the Nasdaq in $212M SPAC deal
Fierce Biotech
Surrozen
regenerative medicine
SPAC
Flag link:
Humacyte sets out to bring regenerative medicine to Wall Street, then the world
Humacyte sets out to bring regenerative medicine to Wall Street, then the world
MedCity News
Humacyte
SPAC
M&A
regenerative medicine
Flag link:
FDA hastens development of Novartis’ Kymriah in follicular lymphoma
FDA hastens development of Novartis’ Kymriah in follicular lymphoma
Pharmaforum
Novartis
Kymriah
follicular lymphoma
FDA
regenerative medicine
Flag link:
Rexgenero CEO Talks Importance of “Dialogue” in Cell Therapy Conversations
Rexgenero CEO Talks Importance of “Dialogue” in Cell Therapy Conversations
Xconomy
cell therapy
Rexgenero
regenerative medicine
Flag link:
Struggling Adaptimmune gets a boost from the FDA as T-cell cancer drug wins an inside track at the agency
Struggling Adaptimmune gets a boost from the FDA as T-cell cancer drug wins an inside track at the agency
Endpoints
Adaptimmune
FDA
regenerative medicine
RMAT
ADP-A2M4
Flag link:
Histogen Treatment for Female Hair Loss Cleared for Clinical Testing
Histogen Treatment for Female Hair Loss Cleared for Clinical Testing
Xconomy
Histogen
hair loss
FDA
nascent skin cells
regenerative medicine
Flag link:
A go-go FDA is opening up the fast lane to regenerative med approvals
A go-go FDA is opening up the fast lane to regenerative med approvals
Endpoints
FDA
regenerative medicine
drug approvals
Flag link:
Big names, big companies back a cell therapy startup run by a high-profile regenerative med expert
Big names, big companies back a cell therapy startup run by a high-profile regenerative med expert
Endpoints
cell therapy
startups
regenerative medicine
Celgene
Hariri
R&D
Flag link:

Pages